Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2023 Earnings Call Transcript February 15, 2024 Ultragenyx Pharmaceutical Inc. beats earnings expectations. Reported EPS is $-1.52, expectations were $-1.65. Ultragenyx Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome […]
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2023 Financial Results Conference Call.
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Operator: Good morning. My name is Kevin. And welcome to Moderna s Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.